Pfizer Wants Justices To Review Lipitor Antitrust Ruling
Pfizer Inc. and generic-drug maker Ranbaxy Inc. have asked the U.S. Supreme Court to review a decision by the Third Circuit to revive allegations in multidistrict litigation accusing Pfizer of making...To view the full article, register now.
Already a subscriber? Click here to view full article